Ask AI

Beyond Resistance: Integrating Next-Generation SERDs Into Community Management of ER-Positive/HER2-Negative Advanced Breast Cancer

Gain expert insights into the latest clinical data and recommendations on next-generation SERDs to optimize care and improve outcomes in patients with ER-positive/HER2-negative advanced breast cancer through a ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Events

Activities

SERDs in ABC
ClinicalThought Expert Office Hours Forum: Integrating Next-Generation SERDs in Advanced Breast Cancer 
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 11, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Supported by educational grants from Lilly and Stemline Therapeutics, Inc.

Lilly

Stemline Therapeutics, Inc.